Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytomegalovirus
New methods may improve management of late CMV infection following SCT
September 9th, 2004
New methods may improve the management of late cytomegalovirus infection following stem cell transplantation. According to recent research published in the journal Human Immunology, "Cytomegalovirus (CMV) infection is one of the most important infectious complications after stem cell transplantation (SCT). "Major improvements in the management of CMV infection have been achieved during the last decade, including the introduction of safe blood product support for CMV-seronegative patients, the development of early pre-emptive antiviral therapy based on sensitive diagnostic tests, and antiviral prophylaxis." "With the better...
Source: Blood Weekly (2004-09-09)
|
